IDEXX Laboratories Inc
IDXX514.330USD
-2.170-0.42%
Cierre 05/28, 16:00（ET）Cotizaciones retrasadas 15 min
41.53BCap. mercado
46.77P/E TTM
Más Datos de IDEXX Laboratories Inc Compañía
IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, dairy and water testing industries. The Company also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
Información de la empresa
Código de la empresaIDXX
Nombre de la empresaIDEXX Laboratories Inc
Fecha de salida a bolsaJun 21, 1991
Fundada en1983
Director ejecutivoMr. Andrew Emerson
Número de empleados11000
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 21
DirecciónOne Idexx Drive
CiudadWESTBROOK
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal04092-2041
Teléfono12075560300
Sitio Webhttps://www.idexx.com/
Código de la empresaIDXX
Fecha de salida a bolsaJun 21, 1991
Fundada en1983
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brian P. Mckeon
Mr. Brian P. Mckeon
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
29.92K
+0.16%
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Mr. Daniel M. (Dan) Junius
Mr. Daniel M. (Dan) Junius
Independent Director
Independent Director
3.00K
+9.56%
Mr. Andrew Emerson
Mr. Andrew Emerson
Executive Vice President, Chief Executive Officer, Treasurer
Executive Vice President, Chief Executive Officer, Treasurer
2.40K
--
Mr. Michael Schreck
Mr. Michael Schreck
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience
1.92K
+112.86%
Mr. Bruce L. Claflin
Mr. Bruce L. Claflin
Independent Director
Independent Director
1.72K
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Brian P. Mckeon
Mr. Brian P. Mckeon
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
29.92K
+0.16%
Mr. Michael Erickson, Ph.D.
Mr. Michael Erickson, Ph.D.
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine
12.58K
+18.05%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
8.69K
+3.11%
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Chairman of the Board
Independent Chairman of the Board
8.23K
+4.39%
Mr. Michael J. Lane
Mr. Michael J. Lane
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology
7.70K
+0.61%
Ms. Sharon E. Underberg
Ms. Sharon E. Underberg
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
5.93K
+8.90%
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
CAG Diagnostics recurring revenue
3.13B
80.29%
Reference laboratory diagnostic and consulting services
1.34B
34.28%
IDEXX VetLab consumables
1.30B
33.44%
Rapid assay products
359.75M
9.23%
CAG Diagnostics capital - instruments
312.62M
8.02%
Other
-2.54B
-65.27%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
2.53B
64.99%
Other Euorpe
196.31M
5.04%
Germany
173.68M
4.46%
Canada
152.88M
3.92%
United Kingdom
134.63M
3.45%
Other
706.82M
18.14%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
CAG Diagnostics recurring revenue
3.13B
80.29%
Reference laboratory diagnostic and consulting services
1.34B
34.28%
IDEXX VetLab consumables
1.30B
33.44%
Rapid assay products
359.75M
9.23%
CAG Diagnostics capital - instruments
312.62M
8.02%
Other
-2.54B
-65.27%
Accionista
Hora de actualización: sáb., 17 de may
Hora de actualización: sáb., 17 de may
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
12.12%
BlackRock Institutional Trust Company, N.A.
6.71%
State Street Global Advisors (US)
4.50%
Fundsmith LLP
3.27%
Geode Capital Management, L.L.C.
2.97%
Other
70.43%
Estadísticas de accionistas
Accionista
Proporción
The Vanguard Group, Inc.
12.12%
BlackRock Institutional Trust Company, N.A.
6.71%
State Street Global Advisors (US)
4.50%
Fundsmith LLP
3.27%
Geode Capital Management, L.L.C.
2.97%
Other
70.43%
Tipo
Accionista
Proporción
Investment Advisor
44.09%
Investment Advisor/Hedge Fund
40.77%
Research Firm
4.09%
Pension Fund
2.24%
Bank and Trust
2.04%
Hedge Fund
1.84%
Sovereign Wealth Fund
1.31%
Individual Investor
0.67%
Family Office
0.47%
Other
2.48%
Participación institucional
Hora de actualización: dom., 19 de ene
Hora de actualización: dom., 19 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
2230
77.53M
95.67%
-2.91M
2024Q4
2242
76.14M
93.59%
-5.30M
2024Q3
2152
77.90M
94.66%
-4.67M
2024Q2
2140
80.09M
96.98%
-924.14K
2024Q1
2154
77.56M
93.40%
-2.57M
2023Q4
2187
77.94M
93.84%
-2.83M
2023Q3
2153
79.23M
95.34%
-677.16K
2023Q2
2157
77.53M
93.40%
-1.56M
2023Q1
2158
77.14M
92.96%
-2.07M
2022Q4
2124
77.44M
93.49%
-2.66M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
9.67M
11.94%
-29.32K
-0.30%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
5.32M
6.57%
-239.97K
-4.31%
Dec 31, 2024
State Street Global Advisors (US)
3.64M
4.49%
+24.20K
+0.67%
Dec 31, 2024
Fundsmith LLP
2.66M
3.29%
-1.31K
-0.05%
Dec 31, 2024
Geode Capital Management, L.L.C.
2.30M
2.83%
+37.73K
+1.67%
Dec 31, 2024
Baron Capital Management, Inc.
2.01M
2.47%
+82.26K
+4.28%
Dec 31, 2024
T. Rowe Price Associates, Inc.
1.05M
1.29%
-375.34K
-26.42%
Dec 31, 2024
Invesco Capital Management (QQQ Trust)
1.69M
2.09%
+22.74K
+1.36%
Feb 28, 2025
BlackRock Asset Management Ireland Limited
1.13M
1.39%
+36.40K
+3.33%
Dec 31, 2024
Principal Global Investors (Equity)
711.20K
0.88%
-19.27K
-2.64%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: vie., 2 de may
Hora de actualización: vie., 2 de may
Nombre
Proporción
ProShares Pet Care ETF
9.82%
First Trust Water ETF
3.82%
iShares U.S. Medical Devices ETF
3.79%
Inspire Tactical Balanced ETF
2.66%
First Trust S&P 500 Economic Moat Index ETF
1.91%
American Century Mid Cap Growth Impact ETF
1.83%
Putnam Sustainable Future ETF
1.8%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
1.7%
Tema Monopolies and Oligopolies ETF
1.59%
Invesco S&P 500 Equal Weight Health Care ETF
1.57%
Ver más
ProShares Pet Care ETF
Proporción9.82%
First Trust Water ETF
Proporción3.82%
iShares U.S. Medical Devices ETF
Proporción3.79%
Inspire Tactical Balanced ETF
Proporción2.66%
First Trust S&P 500 Economic Moat Index ETF
Proporción1.91%
American Century Mid Cap Growth Impact ETF
Proporción1.83%
Putnam Sustainable Future ETF
Proporción1.8%
First Trust NASDAQ-100 Ex-Technology Sector Index Fund
Proporción1.7%
Tema Monopolies and Oligopolies ETF
Proporción1.59%
Invesco S&P 500 Equal Weight Health Care ETF
Proporción1.57%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
